| UniProt ID | SCF_HUMAN | |
|---|---|---|
| UniProt AC | P21583 | |
| Protein Name | Kit ligand | |
| Gene Name | KITLG | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 273 | |
| Subcellular Localization |
Isoform 1: Cell membrane Single-pass type I membrane protein. Isoform 2: Cytoplasm . Cytoplasm, cytoskeleton. Cell membrane Single-pass type I membrane protein. Cell projection, lamellipodium . Cell projection, filopodium . Soluble KIT ligand: Secret |
|
| Protein Description | Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins.. | |
| Protein Sequence | MKKTQTWILTCIYLQLLLFNPLVKTEGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGALYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MKKTQTWILTCIY --CCHHHHHHHHHHH | 21.50 | 27174698 | |
| 10 | Phosphorylation | KTQTWILTCIYLQLL HHHHHHHHHHHHHHH | 6.42 | 27174698 | |
| 13 | Phosphorylation | TWILTCIYLQLLLFN HHHHHHHHHHHHHHC | 7.19 | 27174698 | |
| 27 | Sulfoxidation | NPLVKTEGICRNRVT CHHHCCCCHHCCCCC | 29.54 | 8762148 | |
| 34 | Phosphorylation | GICRNRVTNNVKDVT CHHCCCCCCCHHHHH | 20.17 | 28060719 | |
| 36 | Sulfoxidation | CRNRVTNNVKDVTKL HCCCCCCCHHHHHHH | 32.61 | 8762148 | |
| 48 | Sulfoxidation | TKLVANLPKDYMITL HHHHHCCCCCEEEEE | 27.55 | 8762148 | |
| 90 | N-linked_Glycosylation | DLLDKFSNISEGLSN HHHHHHCCCCHHHCC | 44.96 | 1381905 | |
| 90 | N-linked_Glycosylation | DLLDKFSNISEGLSN HHHHHHCCCCHHHCC | 44.96 | 1381905 | |
| 118 | N-linked_Glycosylation | LVECVKENSSKDLKK HHHHHHHCCCHHHHH | 45.96 | 1381905 | |
| 118 | N-linked_Glycosylation | LVECVKENSSKDLKK HHHHHHHCCCHHHHH | 45.96 | 1381905 | |
| 126 | Phosphorylation | SSKDLKKSFKSPEPR CCHHHHHHCCCCCCC | 36.00 | 30108239 | |
| 128 | Ubiquitination | KDLKKSFKSPEPRLF HHHHHHCCCCCCCCC | 72.67 | - | |
| 128 (in isoform 2) | Ubiquitination | - | 72.67 | - | |
| 129 | Phosphorylation | DLKKSFKSPEPRLFT HHHHHCCCCCCCCCC | 32.27 | 30108239 | |
| 136 | Phosphorylation | SPEPRLFTPEEFFRI CCCCCCCCHHHHHHH | 34.09 | 30108239 | |
| 145 | N-linked_Glycosylation | EEFFRIFNRSIDAFK HHHHHHHHHHHHHHH | 34.12 | 1381905 | |
| 145 | N-linked_Glycosylation | EEFFRIFNRSIDAFK HHHHHHHHHHHHHHH | 34.12 | 1381905 | |
| 146 (in isoform 3) | Ubiquitination | - | 25.00 | 21906983 | |
| 152 | Ubiquitination | NRSIDAFKDFVVASE HHHHHHHHCCEEEEC | 52.56 | - | |
| 159 | Sulfoxidation | KDFVVASETSDCVVS HCCEEEECCCCCEEE | 42.46 | 8762148 | |
| 167 | O-linked_Glycosylation | TSDCVVSSTLSPEKD CCCCEEECCCCCCCC | 23.04 | 1381905 | |
| 168 | O-linked_Glycosylation | SDCVVSSTLSPEKDS CCCEEECCCCCCCCC | 24.61 | 1381905 | |
| 180 | O-linked_Glycosylation | KDSRVSVTKPFMLPP CCCCCEECCCCCCCH | 26.03 | 1381905 | |
| 181 | Ubiquitination | DSRVSVTKPFMLPPV CCCCEECCCCCCCHH | 33.82 | 21906983 | |
| 181 (in isoform 1) | Ubiquitination | - | 33.82 | 21906983 | |
| 195 | N-linked_Glycosylation | VAASSLRNDSSSSNR HHHHHHCCCCCCCCC | 59.83 | UniProtKB CARBOHYD | |
| 231 (in isoform 3) | Ubiquitination | - | 9.21 | 21906983 | |
| 238 (in isoform 2) | Ubiquitination | - | 25.23 | 21906983 | |
| 243 | Phosphorylation | YWKKRQPSLTRAVEN HHHHHCCCHHHHHHH | 33.75 | 23312004 | |
| 261 | Phosphorylation | NEEDNEISMLQEKER CCCCCCHHHHHHHHH | 13.78 | 25841592 | |
| 266 | Ubiquitination | EISMLQEKEREFQEV CHHHHHHHHHHHHCC | 49.46 | 2190698 | |
| 266 (in isoform 1) | Ubiquitination | - | 49.46 | 21906983 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SCF_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 90 | N | Glycosylation |
| 1381905 |
| 90 | N | Glycosylation |
| 1381905 |
| 97 | N | Glycosylation |
| 1381905 |
| 97 | N | Glycosylation |
| 1381905 |
| 118 | N | Glycosylation |
| 1381905 |
| 118 | N | Glycosylation |
| 1381905 |
| 145 | N | Glycosylation |
| 1381905 |
| 145 | N | Glycosylation |
| 1381905 |
| 167 | S | Glycosylation |
| 1381905 |
| 167 | S | Glycosylation |
| 1381905 |
| 168 | T | Glycosylation |
| 1381905 |
| 168 | T | Glycosylation |
| 1381905 |
| 180 | T | Glycosylation |
| 1381905 |
| 180 | T | Glycosylation |
| 1381905 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SCF_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SCF_HUMAN | KITLG | physical | 8626683 | |
| SCF_HUMAN | KITLG | physical | 10884405 | |
| AT8B2_HUMAN | ATP8B2 | physical | 26186194 | |
| PIGU_HUMAN | PIGU | physical | 26186194 | |
| KLD10_HUMAN | KLHDC10 | physical | 26186194 | |
| FLT3L_HUMAN | FLT3LG | physical | 25241761 | |
| KLD10_HUMAN | KLHDC10 | physical | 28514442 | |
| AT8B2_HUMAN | ATP8B2 | physical | 28514442 | |
| S22AI_HUMAN | SLC22A18 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| H00884 | Familial progressive hyperpigmentation | |||||
| OMIM Disease | ||||||
| 145250 | Hyperpigmentation with or without hypopigmentation, familial progressive (FPHH) | |||||
| Kegg Drug | ||||||
| D02937 | Ancestim (genetical recombination) (JAN); Ancestim (USAN/INN); Stemgen (TN) | |||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Post-translational processing of membrane-associated recombinanthuman stem cell factor expressed in Chinese hamster ovary cells."; Lu H.S., Clogston C.L., Wypych J., Parker V.P., Lee T.D., Swiderek K.,Baltera R.F. Jr., Patel A.C., Chang D.C., Brankow D.W., Liu X.-D.,Ogden S.G., Karkare S.B., Hu S.S., Zsebo K.M., Langley K.E.; Arch. Biochem. Biophys. 298:150-158(1992). Cited for: PROTEIN SEQUENCE OF 26-40; 64-79; 87-102; 110-149 AND 154-190 (ISOFORM1), DISULFIDE BONDS, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, ANDGLYCOSYLATION AT ASN-90; ASN-118; ASN-145; SER-167; THR-168 ANDTHR-180. | |
| O-linked Glycosylation | |
| Reference | PubMed |
| "Post-translational processing of membrane-associated recombinanthuman stem cell factor expressed in Chinese hamster ovary cells."; Lu H.S., Clogston C.L., Wypych J., Parker V.P., Lee T.D., Swiderek K.,Baltera R.F. Jr., Patel A.C., Chang D.C., Brankow D.W., Liu X.-D.,Ogden S.G., Karkare S.B., Hu S.S., Zsebo K.M., Langley K.E.; Arch. Biochem. Biophys. 298:150-158(1992). Cited for: PROTEIN SEQUENCE OF 26-40; 64-79; 87-102; 110-149 AND 154-190 (ISOFORM1), DISULFIDE BONDS, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, ANDGLYCOSYLATION AT ASN-90; ASN-118; ASN-145; SER-167; THR-168 ANDTHR-180. | |